Actavis to distribute Irinotecan Hydrochloride Injection in the US

Generic pharmaceuticals group Actavis extends its US portfolio with first injectable product. Actavis Group, the international generic pharmaceuticals company, has received approval for Irinotecan Hydrochloride Injection from the US Food & Drug Administration. Distribution of the product will commence immediately. Irinotecan Hydrochloride Injection, the generic equivalent to Pfizer’s Camptosar®, will be available ... Read More...